Publicaciones en colaboración con investigadores/as de Hospital Universitario La Paz (6)

2020

  1. Biological and clinical significance of dysplastic hematopoiesis in patients with newly diagnosed multiple myeloma

    Blood, Vol. 135, Núm. 26, pp. 2375-2387

2018

  1. Multicenter comparison of CD34+ myeloid cell count by flow cytometry in low-risk myelodysplastic syndrome. Is it feasible?

    Cytometry Part B - Clinical Cytometry, Vol. 94, Núm. 3, pp. 527-535

2017

  1. Depth of response in multiple myeloma: A pooled analysis of three PETHEMA/GEM clinical trials

    Journal of Clinical Oncology, Vol. 35, Núm. 25, pp. 2900-2910

  2. Excess mortality in the myelodysplastic syndromes

    American Journal of Hematology, Vol. 92, Núm. 2, pp. 149-154

2015

  1. Use of newer prognostic indices for patients with myelodysplastic syndromes in the low and intermediate-1 risk categories: A population-based study

    The Lancet Haematology, Vol. 2, Núm. 6, pp. e260-e266

2014

  1. Results of treatment with azacitidine in patients aged ≥ 75 years included in the Spanish Registry of Myelodysplastic Syndromes

    Leukemia and Lymphoma, Vol. 55, Núm. 6, pp. 1300-1303